Skip to content

Exelixis EXEL Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Pfizer logo
PfizerPFE
$159.73B+11.1%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$14.7B+3.3%
Incyte logo
IncyteINCY
$18.73B+59.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.4B+159%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$14.4B+119%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Computed from the period-end share price: $11.29B.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's market capitalization?
Exelixis (EXEL) reported market capitalization of $11.29B in Q1 2026.
How has Exelixis's market capitalization changed year-over-year?
Exelixis's market capitalization increased by 10.1% year-over-year, from $10.25B to $11.29B.
What is the long-term trend for Exelixis's market capitalization?
Over 5 years (2020 to 2025), Exelixis's market capitalization has grown at a 9.6% compound annual growth rate (CAGR), from $7.03B to $11.09B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.